1. Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?
   Ming Wu et al, 2022, Frontiers in Public Health CrossRef
2. The significance of nonsurgical therapies for cervical infection of high‐risk human papilloma virus: A systematic review and meta‐analysis
   Yuan Zhuang et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
3. The association of cervical cancer screening and quality of care: A systematic analysis of the Global Burden of Disease Study 2019
   Minmin Wang et al, 2023, Journal of Global Health CrossRef
4. Cervical cancer: Novel treatment strategies offer renewed optimism
   Gangotri yadav et al, 2024, Pathology - Research and Practice CrossRef
5. Human papillomavirus (HPV) vaccination: a call for action in Italy
   Giorgio Bogani et al, 2023, International Journal of Gynecologic Cancer CrossRef
6. Upregulation of TMEM40 is associated with the malignant behavior and promotes tumor progression in cervical cancer
   Zhen-Fei Zhang et al, 2023, Discover Oncology CrossRef
7. Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives
   Patryk Poniewierza et al, 2022, Healthcare CrossRef
8. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142–5p/PD-L1 axis
   Junjun Ling et al, 2022, Archives of Biochemistry and Biophysics CrossRef
9. Overcoming obstacles to mammography screening: Examining the role of offline healthcare barriers and online patient–provider communication
   Yuyuan Kylie Lai et al, 2024, Journal of Health Psychology CrossRef
10. Optical imaging for screening and early cancer diagnosis in low-resource settings
    Rebecca Richards-Kortum et al, 2023, Nature Reviews Bioengineering CrossRef